We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
In response to the suspension of elective surgery due to COVID-19 and the significant impact this has had on parts of the medical devices industry, the Government has agreed to provide a 50 per cent reduction in annual charges for certain medical devices. The 50 per cent reduction in annual charges will be prescribed for the 2020-21 financial year for medical devices included in the Australian Register of Therapeutic Goods (ARTG) as Class IIa, IIb, III and AIMD and which are listed prostheses as defined in the Private Health Insurance (Prostheses) Rules (No.1) 2020, as in force on 8 April 2020.
| Class of medical device | Charge | Regulation |
|---|---|---|
| AIMD | $600 | Item 7(4A)(b) |
| Class III | $600 | Item 7(4A)(b) |
| Class IIa | $470 | Item 7(4A)(a) |
| Class IIb | $470 | Item 7(4A)(a) |
These charges are in the Therapeutic Goods (Charges) Regulations 2018
No action is required by eligible sponsors as the Therapeutic Goods Administration (TGA) will use the published Prostheses List (PL) as in force on 8 April 2020 with reference to the ARTG inclusion number to identify those devices which will be subject to the reduced charges.
The reduced annual charge would also apply to an ARTG entry where multiple products are included in the entry and only some products covered by the entry are listed on the PL.
Sponsors will receive an invoice in August for the 2020-21 annual charges, which will automatically include the reduced charges for such devices.
The complete TGA fees and charges schedule is available on the TGA website.
Any questions relating to this can be directed to accountsrec@health.gov.au (for billing and payment) or Email us (for verification of medical device on the PL).